Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of March 28, 2025 • 11:41 AM ET

Date/Time Source News Release
03/25/2025 04:30 PM EDT PR Newswire Elevation Oncology to Present Preclinical Data for EO-1022 at the American Association for Cancer Research (AACR) Annual Meeting 2025
03/20/2025 08:00 AM EDT PR Newswire Elevation Oncology to Discontinue Development of EO-3021; Advancing EO-1022, While Evaluating Strategic Options
03/06/2025 04:30 PM EST PR Newswire Elevation Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Achievements
02/25/2025 07:30 AM EST PR Newswire Elevation Oncology to Participate in Upcoming Investor Conferences
01/13/2025 07:30 AM EST PR Newswire Elevation Oncology Provides Updates on Differentiated ADC Programs and Upcoming Milestones
12/12/2024 07:30 AM EST PR Newswire Elevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-expressing Solid Tumors
12/05/2024 07:30 AM EST PR Newswire Elevation Oncology Presents Preclinical Proof-of-Concept Data Supporting Combination Potential of EO-3021 with VEGFR2 or PD-1 Inhibitors at ESMO Immuno-Oncology Annual Congress 2024
11/26/2024 07:30 AM EST PR Newswire Elevation Oncology to Present at the Piper Sandler 36th Annual Healthcare Conference
11/06/2024 07:30 AM EST PR Newswire Elevation Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business Achievements
09/23/2024 07:30 AM EDT PR Newswire Elevation Oncology Receives Fast Track Designation from the FDA for EO-3021 for the Treatment of Adult Patients with Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer Expressing Claudin 18.2
Page

Additional News

As of March 28, 2025 • 11:41 AM ET

Date/Time Source News Release
03/21/2025 01:03 PM EDT Zacks Elevation Oncology Plunges 42% on Ending Development of Lead Drug
03/20/2025 09:09 AM EDT SeekingAlpha Elevation Oncology slumps on plans to drop cancer candidate
03/06/2025 04:47 PM EST SeekingAlpha Elevation Oncology GAAP EPS of -$0.18 beats by $0.04
03/05/2025 06:00 AM EST US Earnings Reports Expected US Company Earnings on Wednesday, March 5th, 2025
03/05/2025 04:31 AM EST US Earnings Reports Expected earnings - Elevation Oncology Inc.
01/15/2025 10:06 AM EST Markets and Headlines Cutting-Edge Cancer Therapies Lead the Way into a Transformative Year
11/16/2024 04:38 AM EST US Earnings Reports Expected earnings - Elevation Oncology Inc.
11/06/2024 10:41 AM EST SeekingAlpha Elevation Oncology GAAP EPS of -$0.22 misses by $0.02
11/01/2024 10:47 AM EDT Zacks AGIO's Q3 Earnings Miss Mark, Revenues In Line, Stock Down
11/01/2024 10:19 AM EDT Zacks United Therapeutics Q3 Earnings & Sales Beat Estimates
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.